
11 - 50 employees
🧬 Biotechnology
💊 Pharmaceuticals
💰 $300k Grant - BrainChild Bio on 2025-01
Biotechnology • Pharmaceuticals
<BrainChild Bio> is a clinical-stage biotechnology company developing CAR T-cell therapies targeting tumors in the central nervous system (CNS). The company prioritizes pediatric brain tumors while extending its platform to adult indications such as glioblastoma and brain metastases, aiming to advance novel cell therapies through the clinic and translate its science broadly to improve outcomes for children and adults with CNS cancers.
🔥 1 hour ago
Director in Regulatory Affairs at BrainChild Bio leading CMC regulatory strategies for cell therapies. Ensuring quality, safety, and compliance for clinical-stage products.